The lowest price linkage we are in action
Release time:
2020-08-14
Minimum Price Linkage We are in Action
- @ All salesmen: Please come to the conference room for a meeting at noon 12 : 00 . Please tell each other to attend on time regarding the implementation of the minimum price linkage.
-Who is the fourth person to rush the tickets? We can do it.
- @ Li zong has customers who do not have enough funds when they rush tickets, please ask the finance department to add funds.
- @ Jiang zong storage handheld system is out of order, please contact the system maintainers quickly.
-Yongkang Shizhu and Yongkang Jiangnan Streets are ready for invoicing.
-Jinhua Fifth Hospital is ready to issue invoices.
-Wuyi Hospital of Traditional Chinese Medicine is ready to issue invoices.
......
In order to respond to the major event of "the national lowest price linkage of drugs in Zhejiang Province", since the late June of this year, the WeChat group in Jinhua Pharmaceutical Company has been very lively, including business departments, storage departments, logistics support departments and members of the company's team, the information of asking for instructions, consulting, notifying and serving continues one after another, and such "excitement" will continue until the end of 3 .
2 March 21 , according to the documents of Zhejiang province drug centralized procurement working group office, the provincial drug equipment procurement center issued a notice requiring all medical institutions and distribution enterprises to uniformly implement the national lowest price linkage of online trading products in Zhejiang province from 3 July 1 , and the linkage price is directly used as the new purchase price in procurement and distribution, the actual transaction price shall not be higher than the linkage price. For this reason, the purchasing, sales, storage and other relevant departments of the municipal pharmaceutical company have taken active actions. The sales department has organized training for all salesmen to understand the policies and be familiar with the operation process. The original distribution price (high price) of drugs originally distributed to various medical institutions has been changed to the linkage price (low price). The purchasing department will communicate with the upstream suppliers to adjust the price to make up the difference. Starting from January , all salesmen of the pharmaceutical company will make use of the time when they do not deliver goods on weekends to make virtual returns for their respective medical institutions at the original price. The employees of the storage department will make virtual inspections, receive goods and put them into storage. Then the salesmen will make out invoices at the linked price. The storage department will make virtual operations such as putting drugs on shelves, distributing goods, checking and delivering goods, each link of the whole operation process needs to check the medical unit, variety, batch number and other information.
In this minimum price linkage adjustment, the municipal pharmaceutical company has nearly,200 medical institutions involved, with more than ,1000 varieties. Moreover, each medical institution will have the same variety and different batch numbers of the same variety. Therefore, the number of operations requiring minimum price linkage is counted geometrically, and the workload is quite large. In order to avoid staggering and staggering, all these operations must be carried out without delivery in the warehouse department, so all relevant personnel can only use the weekend break to work together and work overtime to complete. (Fan Tufa)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page